Speakers

Thursday, April 9

Keynote

Ramnik Xavier, M.D.

The microbiome, immunity, and inflammatory bowel disease
Ramnik Xavier, M.D.
Core Member, Director of the Immunology Program and Co-Director of Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard
Kurt J. Isselbacher Professor of Medicine, Harvard Medical School

HIV

Jason Brenchley, Ph.D.

Microbiome contributions to progressive HIV/SIV infection
Jason Brenchley, Ph.D.
Senior Investigator, Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health

Matthew Hayward, Ph.D.

Bacterial Strain Differences in the Reproductive Tract and Their Associated Immunophenotypes
Matthew Hayward, Ph.D.
Research Fellow in Medicine, Ragon Institute of MGH, MIT and Harvard

Sujatha Srinivasan, Ph.D.

Vaginal bacteria and HIV acquisition in women
Sujatha Srinivasan, Ph.D.
Senior Staff Scientist, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center

Models of Disease

Robert A. Britton, Ph.D.

Development of Defined Communities for the Prevention and Treatment of C. difficile Infection
Robert A. Britton, Ph.D.
Professor, Department of Molecular Virology and Microbiology
Member, and Director of the Bioreactor and Cultivation Core, Alkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine

Motoko Koyama, M.D., Ph.D.

Microbiota Promote MHC Class II Antigen Presentation by Intestinal Epithelial Cells to Initiate Graft-Versus-Host Disease
Motoko Koyama, M.D., Ph.D.
Senior Staff Scientist, Clinical Research Division, Fred Hutchinson Cancer Research Center

Melissa Kordahi

Biogeographies of Bacteroides fragilis in early colorectal cancer
Melissa Kordahi
Ph.D. Candidate, DePaolo Lab, Molecular Medicine and Mechanisms of Disease (M3D) Program, University of Washington

Pediatrics

Gautam Dantas, Ph.D.

Predicting and combating biotic and abiotic disruptions to diverse microbiomes
Gautam Dantas, Ph.D.
Professor, Departments of Pathology & Immunology, Biomedical Engineering, and Molecular Microbiology, and the Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine in St. Louis

Short Talks

Kevin Forsberg

Kevin Forsberg, Ph.D.
Post-Doctoral Research Fellow, Malik Lab, Basic Sciences Division, Fred Hutchinson Cancer Research Center

Jeff McLean

Jeffrey McLean, Ph.D.
Associate Professor, School of Dentistry and Adjunct Associate Professor, Department of Microbiology, University of Washington

Sandi Navarro

Sandi Navarro, Ph.D.
Staff Scientist, Public Health Sciences Division, Fred Hutchinson Cancer Research Center

Jeanette Schwensen

Jeanette Schwensen, B.S.
Research Technician, Koch Lab, Basic Sciences Division, Fred Hutch

Friday, April 10

Keynote

Janet Jansson, Ph.D.

Microbiomes in Transition
Janet Jansson, Ph.D.
Chief Scientist for Biology and Lab Fellow, Biological Sciences Division, Pacific Northwest National Laboratory

Therapeutics

Bruce Roberts, Ph.D.

A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
Bruce Roberts, Ph.D.
Chief Scientific Officer, Vedanta Biosciences

Scott Olesen, Ph.D.


Improving Safety and Scale: The Role of Stool Banks in C. difficile Treatment and in Research
Scott Olesen, Ph.D.
Scientific Director, OpenBiome

David L. Suskind, M.D.

Diet, inflammatory bowel disease and the intestinal microbiome
David L. Suskind, M.D.
Physician Lead ImproveCareNow, Seattle Children's Hospital
Professor of Pediatrics, Division of Gastroenterology, Department of Pediatrics, University of Washington

Biostatistics

Michael Wu, Ph.D.

Integrative Analysis of Microbiome and Other -Omics Data
Michael Wu, Ph.D.
Associate Member, Public Health Sciences Division, Fred Hutchinson Cancer Research Center
Affiliate Associate Professor, Department of Biostatistics, School of Public Health, University of Washington

Samuel Minot, Ph.D.

Gene-level metagenomics systematically identifies culturable microbial isolates which are reproducibly associated with human disease
Samuel Minot, Ph.D.
Staff Scientist, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center

Chemistry

Emily Balskus, Ph.D.

Deciphering the human microbiota using chemistry
Emily Balskus, Ph.D.
Professor, Department of Chemistry and Chemical Biology, Harvard University; Member, Broad Institute of MIT and Harvard
Faculty Associate, Microbial Sciences Initiative, Member, MIT Center for Microbiome Informatics and Therapeutics

Pieter C. Dorrestein, Ph.D.

Metabolomics of the microbiome at data repository scale
Pieter C. Dorrestein, Ph.D.
Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, Departments of Pharmacology and Pediatrics
Director, Collaborative Mass Spectrometry Innovation Center
Co-Director, Institute for Metabolomics Medicine, University of California San Diego

Julia Yue Cui, Ph.D.

Developmental Programming of the Gut Microbiome
Julia Yue Cui, Ph.D. 
Sheldon D. Murphy Endowed Chair in Toxicology and Environmental Health and Assistant Professor, Department of Environmental and Occupational Health Sciences, University of Washington

Christopher Johnston, Ph.D.

DNA methylation in bacteria: epigenetics and the microbiome
Christopher Johnston, Ph.D.
Assistant Member, Vaccine and Infectious Disease Division, Fred Hutch